arBtrage CAPITALIZING MARKETS checking… Sign in

COMPASS Pathways Plc

CMPS Health Care Biotechnology: Pharmaceutical Preparations
$12.11
▼ -7.2% Today
as of Jun 7, 07:11 ET
Last 30 days +43.48% Apr 28 → Jun 05
$7.92 $9.60 $11.28 $12.97 $14.65 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$12.94
High
$13.03
Low
$11.74
Volume
$4M
Avg Vol
$3M
Mkt Cap
$1.6B
P/E (TTM)
Beta
52w High
$14.76
52w Low
$2.25
Div Yield
Shares Out
$135M

Overview

52-week range
$2.25
$15
79% of range
Avg surprise (last 2)
+19.9%
Avg reaction (last 2)
+8.8%
100% positive
Latest IV / EM
113%
EM ±15.7% · $12 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-620.00$-465.07$-310.15$-155.22$-0.30 Actual $-620.00Actual $-0.67Actual $-0.55Actual $-0.56Actual $-0.56Actual $-0.44Est $-0.47Actual $-0.41Actual $-1.44Actual $-0.30Est $-0.45 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-138M$-79M$-21M$37M$96M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.30 $-0.45 +33.3% +31.8% +17.0% earnings
Tue Sep 30, 2025Sep 2025 $-1.44 financials
Mon Jun 30, 2025Jun 2025 $-0.41 financials
Thu May 8, 2025Mar/2025 $-0.44 $-0.47 +6.4% +0.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.56 financials
Sun Jun 30, 2024Jun 2024 $-0.56 financials
Sun Mar 31, 2024Mar 2024 $-0.55 financials
Sat Sep 30, 2023Sep 2023 $-0.67 financials
Fri Jun 30, 2023Jun 2023 $-620.00 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-43M$-41M$-43M$-50M$-48M$-43M
Net income$91M$-138M$-38M$-18M$-39M$-38M
EPS (diluted)$-0.30$-1.44$-0.41$-0.24$-0.56$-0.56

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$466M$150M$186M$222M$260M$165M$207M$229M
Inventory
Total current assets$511M$191M$242M$276M$305M$201M$234M$265M
Total assets$532M$210M$256M$294M$319M$214M$247M$279M
Long-term debt$50M$14M$19M$23M$22M$25M$28M
Total liabilities$205M$263M$218M$131M$124M$59M$54M$52M
Total equity$327M$-53M$38M$163M$195M$155M$193M$226M

Implied volatility — last 90 days

108%110%113%115%118% Jun 07 — IV 113% · EM ±15.7%

Sector peers